跳至主要内容
临床试验/NCT05089890
NCT05089890招募中不适用

An Open, Single-centre, Clinical Investigation to Explore the Binding of Bacteria and Fungi to Dialkylcarbamoyl Chloride (DACC)-Coated Dressings From Hard-to-heal Wounds

ABIGO Medical AB1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年4月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
1
主要终点
Bacterial and fungal species irreversibly bound to the dressing after 2 days (+ 1 day).

研究概览

简要总结

The main purpose of this exploratory clinical investigation is to study the binding of bacteria and fungi from hard-to-heal wounds to the DACC-coated dressings.

详细描述

This is a prospective, open, single-centre, exploratory clinical investigation with a primary objective of studying the binding of bacteria and fungi from hard-to-heal wounds to the surface of DACC-coated dressings.

Subjects suffering from hard-to-heal wounds who are due to start using a dressing from the Sorbact range will be recruited at one investigation site in Sweden. The subjects will be divided into three groups by dressing type and there will be 10 subjects in each group, i.e., 10 subjects will be treated with Sorbact® Compress, 10 subjects will be treated with Sorbact® Gel Dressing, and 10 subjects will be treated with Sorbact® Ribbon Gauze. The dressings will be used in accordance with their respective IFU.

The clinical investigation is designed to have a treatment period of 14 days with no additional follow-up.

Three visits are planned for each subject, including a screening/baseline visit at the clinic and two further visits to the study clinic.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Able to read and understand the Subject Information and Informed Consent Form and provide meaningful informed consent
  • Due to start using one of the following dressings: Sorbact® Compress, Sorbact® Gel Dressing and Sorbact® Ribbon Gauze
  • Age ≥18 years
  • Presence of hard-to-heal wound for ≥6 weeks with no significant wound area reduction for the last 4 weeks confirmed by investigator/study nurse

排除标准

  • Participating in another clinical investigation
  • Known allergy or sensitivity to any components of the allocated investigational device
  • Use of antimicrobial agent (e.g., silver- or iodine-containing dressings, or gels) during the last wo weeks
  • Use of a dressing from the Sorbact® range during the last two weeks
  • Subjects with any other condition that as judged by the investigator may make investigation procedures inappropriate

研究组 & 干预措施

Sorbact® Compress

Other

Patients already assigned to start treatment with Sorbact® Compress as it is judged by the investigator to be the most suitable for their wounds

干预措施: Sorbact® Compress (Device)

Sorbact® Gel Dressing

Other

Patients already assigned to start treatment with Sorbact® Gel Dressing as it is judged by the investigator to be the most suitable for their wounds

干预措施: Sorbact® Gel Dressing (Device)

Sorbact® Ribbon Gauze

Other

Patients already assigned to start treatment with Sorbact® Ribbon Gauze as it is judged by the investigator to be the most suitable for their wounds

干预措施: Sorbact® Ribbon Gauze (Device)

结局指标

主要结局

Bacterial and fungal species irreversibly bound to the dressing after 2 days (+ 1 day).

时间窗: 2 days (+1 day)

The measurements that will be used to assess the primary outcome are 16S rRNA sequencing to identify bacterial species, Internal Transcribed Spacer (ITS) sequencing to identify fungal species and scanning electron microscopy (SEM) images for visualization of bacteria and fungi bound to the dressing

次要结局

  • Wound bed microbial load at 14 days (±1 days) compared to baseline(14 days (±1 days))
  • Wound bed bacteria and fungi species at baseline and at 14 days (±1 days)(14 days (±1 days))
  • Wound fluid inflammatory biomarker levels at 14 days (±1 days) compared to baseline(14 days (±1 days))
  • Wound fluid endotoxin level at 14 days (±1 days) compared to baseline(14 days (±1 days))
  • Presence of endotoxin on the dressing after 2 days (+ 1 day)(2 days (+ 1 day))
  • Presence of inflammatory biomarkers on the dressing after 2 days (+ 1 day)(2 days (+ 1 day))

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验